Slope is a global provider of biospecimen lifecycle software, data, and services for clinical trials. With a focus on tech-enabling the full biospecimen lifecycle, Slope offers expertise that empowers sponsors to make informed decisions using high-quality, real-time sample data. Slope has supported thousands of the most complex, sample-intensive trials worldwide and has been adopted by nearly 80% of NCI-designated cancer centers.
Biospecimen360™ is a biospecimen lifecycle software solution that provides sponsors with real-time, compliant, and traceable sample data to inform timely study decisions. The software controls sample metadata capture and orchestrates multi-stakeholder activities and data flow throughout the biospecimen lifecycle — from kit logistics and inventory control to sample collection, processing, storage, and shipping, to receipt at labs. The result is instant data availability across sites, labs, kitters, shippers, and other eClinical systems; this in turn enables faster reconciliation, less risk, and significantly improved study compliance, monitoring, and reporting.
When sites support a trial that uses Biospecimen360™, they gain comprehensive access to advanced inventory and sample management tools that seamlessly guide them through every step of sample collection, processing, storage, and shipping.
Additionally, we provide free inventory management software for sites to use across all of their trials, empowering them to streamline their operations with ease.
-
Industry
-
Biotechnology Research
-
Company size
-
51-200 employees
-
Headquarters
-
Richmond, Virginia
-
Type
-
Privately Held
-
Founded
-
2016
-
Specialties
-
B2B SaaS Software, clinical trial management, sample management, clinical inventory management, data-driven resupply, and clinical trial execution